Roche Diagnostics GmbH
- Aktuellste Pressemitteilung
- Newsroom
- Media Monitor
New Roche Award for Antibody-based Cancer Therapy Research
In a newly created award, pRED's Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invites European researchers to submit abstracts...
Roche lanciert neuen Test zur Diagnose und Verlaufskontrolle von Schilddrüsenkrebs
Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute die weltweite Markteinführung (außer in den USA) des Elecsys Calcitonin Tests bekannt. Hierbei handelt es sich um einen...
German Life Science Award 2013
Die beiden Wissenschaftler Prof. Dr. Shirley Knauer (36), Zentrum für Medizinische Biotechnologie der Universität Duisburg-Essen, und Dr. Michael Hiller (35), Max-Planck-Institut...
Spatenstich für ein neues Diagnostik-Produktionsgebäude - Startschuss für 200 Millionen Euro Investition in Deutschland
Roche feiert heute unter Anwesenheit des Bayerischen Ministerpräsidenten Horst Seehofer den Spatenstich für ein hochmodernes Diagnostika-Produktionsgebäude in Penzberg...
Roche and BioLamina Start Collaboration to Develop Novel Cell Culture Systems
Roche (SIX: RO, ROG; OTCQX: RHHBY) and BioLamina, Stockholm, Sweden today announced the signing of a research and development agreement to jointly develop new cell...
Roche and Hamilton Introduce New Automated DNA Sample Enrichment Platform for GS Junior Sequencing Instruments
Today Roche and Hamilton Robotics jointly announced the introduction of a new, integrated platform enabling automated DNA sample enrichment for Roche's 454 GS Junior...
First European Laboratory Obtains Accreditation for New Tissue-Typing Method for Stem Cell Transplants
The Red Cross Blood Transfusion Service of Upper Austria has become the first laboratory in Europe to receive accreditation from the European Federation for Immunogenetics...
Research Consortium Announces Significant Progress to Close Gaps and Uncover Novel Genes in the Human Reference Genome Sequence
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a consortium consisting of researchers from Penn State University, the National Center for Biotechnology...
Roche launches new SeqCap EZ Reagent Kits to maximize customer convenience
Roche announced today the global launch and availability of a new comprehensive suite of SeqCap EZ Reagent kits for application in single or multiplex target enrichment...
GBM und Roche vergeben German Life Science Award
Die Gesellschaft für Biochemie und Molekularbiologie (GBM) und Roche haben gemeinsam den German Life Science Award für begabte Nachwuchsforscher ausgelobt. Die von...
Roche and PSS sign agreement to develop a fully automated workflow solution for next-generation sequencing platforms
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR...
Roche's rapid mycoplasma detection test MycoTOOL receives FDA acceptance for release testing of biopharmaceutical Roche product
Today Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing...
Roche investiert 240 Millionen Franken in Diagnostika-Produktion in Deutschland
Roche hat heute eine weitere Investition in Höhe von über 240 Millionen Schweizer Franken (über 200 Millionen Euro) in das Biotechnologie-Zentrum des Unternehmens...
Roche and Agilent Technologies Establish Agreement to Provide Continued Service and Support to Roche NimbleGen Microarray Customers
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an exclusive agreement to provide continued service to...
Roche introduces new GS FLX+ software for significantly improved long-read sequencing performance
Roche announced today the launch and immediate availability of a new software package (v2.8) that significantly improves long-read shotgun sequencing performance...
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at www.roche.com.
LIGHTCYCLER and REALTIME READY are trademarks of Roche.
Ansprechpartner
Herr Dr. Johannes Ritter
Telefon +49 (8856) 60-2600
Fax +49 (8856) 60-3417
Frau Bianca Hermle
Kommunikation
Telefon +49 (621) 759-8743
Frau Bianca Hermle auf Xing




